Tissue N-linked glycosylation as potential prognostic biomarker for biochemical recurrence-free survival.
Tijl VermassenArne Van Den BroeckNicolaas LumenNico CallewaertSylvie RotteyJoris DelanghePublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2021)
Tissue N-glycans are a powerful prognostic tool and can be an asset in PCa as the ratio of 3AFc/MA is independently associated with BCR-free survival. This could be of clinical use in guiding patients following radical prostatectomy, e.g. referral to adjuvant radiotherapy. Further elaboration of this biomarker is warranted.